Robert Kramer was the CEO of Emergent BioSolutions, a government contractor.
New York's attorney general has filed an insider trading lawsuit against former Emergent BioSolutions CEO Robert Kramer, ...
Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...
By Jonathan Stempel NEW YORK, Jan 15 (Reuters) - A former chief executive of Emergent BioSolutions was charged on Thursday ...
The federal government has canceled a multimillion dollar deal with Emergent BioSolutions, a Maryland-based vaccine manufacturer with facilities in Baltimore that were found to have produced millions ...